These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19014549

  • 21. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetzky M, Kemp JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipane GA, Wanderer A, Cuss FM, Nolop KB, Harrison JE.
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [Abstract] [Full Text] [Related]

  • 22. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
    Nathan RA, Nayak AS, Graft DF, Lawrence M, Picone FJ, Ahmed T, Wolfe J, Vanderwalker ML, Nolop KB, Harrison JE.
    Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
    [Abstract] [Full Text] [Related]

  • 23. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H.
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J, D'Urzo A, Hebert J, Barraza CH, Boulet LP, Suárez-Chacón R, Harnest U, Lundbäck B, Martinez Morales G, Nieminen MM, Nolop KB, Visser S, Lutsky BN.
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [Abstract] [Full Text] [Related]

  • 25. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H.
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [Abstract] [Full Text] [Related]

  • 26. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B.
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [Abstract] [Full Text] [Related]

  • 27. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
    Holgate ST, Arshad H, Stryszak P, Harrison JE.
    J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
    [Abstract] [Full Text] [Related]

  • 28. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
    Skoner DP, Meltzer EO, Milgrom H, Stryszak P, Teper A, Staudinger H.
    J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
    [Abstract] [Full Text] [Related]

  • 29. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T, Cutler DL, Staudinger H, Herron JM.
    Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
    [Abstract] [Full Text] [Related]

  • 30. Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
    Schmier J, Leidy NK, Gower R.
    J Asthma; 2003 Jun; 40(4):383-93. PubMed ID: 12870834
    [Abstract] [Full Text] [Related]

  • 31. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.
    Zeidler M, Corren J, Tashkin DP.
    Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376
    [Abstract] [Full Text] [Related]

  • 32. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M, Jarvis B.
    Drugs; 2001 Jun; 61(9):1325-50. PubMed ID: 11511026
    [Abstract] [Full Text] [Related]

  • 33. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
    van Zyl-Smit RN, Krüll M, Gessner C, Gon Y, Noga O, Richard A, de Los Reyes A, Shu X, Pethe A, Tanase AM, D'Andrea P, PALLADIUM trial investigators.
    Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
    [Abstract] [Full Text] [Related]

  • 34. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
    D'Urzo A.
    Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 36. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y, Miyamoto T.
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [Abstract] [Full Text] [Related]

  • 37. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [Abstract] [Full Text] [Related]

  • 38. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U, Price D, Howes T, Sussman G.
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [Abstract] [Full Text] [Related]

  • 39. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
    Weinstein SF, Corren J, Murphy K, Nolte H, White M, Study Investigators of P04431.
    Allergy Asthma Proc; 2010 Apr; 31(4):280-9. PubMed ID: 20687982
    [Abstract] [Full Text] [Related]

  • 40. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.